Topic
AI Capex Research
Current research indicates that AI infrastructure demand remains a primary driver for equity market strength, contributing significantly to a 26% year-over-year earnings growth in Q1 2026. This momentum has prompted revisions to market targets, with the S&P 500 projected to reach 8,000, supported by software gains and hardware innovations like Nvidia’s RTX Spark chip. Beyond mega-cap tech, AI-related capital expenditure is fostering a turnaround in small-cap equities and driving renewed M&A activity within the sector. The capital commitment to this space is further highlighted by high-profile moves such as Anthropic’s IPO filing, even as broader markets face headwinds from sticky inflation and headline PCE at 3.8%. Despite these macroeconomic pressures and rising energy costs, institutional flows remain concentrated in US large-cap products that capture AI growth. Ultimately, the research suggests that while inflationary risks persist, the secular trend of AI capex continues to underpin global equity sentiment and valuation expansions.
4230 reports available
All reports
Page 151 of 164
Technical Views Equity Indices
Pictet · May 11, 2026
Vodacom Mixed FY26 Results Reassuring on South African Growth
Goldman Sachs · May 11, 2026
How Can I Invest in Transformational Innovation
UBS · May 11, 2026
Leidos Holdings Solid Quarter
Goldman Sachs · May 11, 2026
Dividend Screener
UBS · May 11, 2026
Upwork Q1 2026 Review
Goldman Sachs · May 11, 2026
Swiss Economy in 20 Charts
UBS Switzerland AG · May 11, 2026
Joby Aviation Flight Demonstrations Underway
Goldman Sachs · May 11, 2026
China AIDC and Power Virtual Corporate Day Takeaways
Goldman Sachs · May 11, 2026
Fast FX Fair Value Model Back to Selling Nok Sek
Crédit Agricole CIB · May 11, 2026
Record US Stocks Disconnect or Not
BlackRock · May 11, 2026
Investor Day: High Growth Portfolio Achieved Critical Mass
Goldman Sachs · May 11, 2026
Midday Market Intelligence
Goldman Sachs · May 11, 2026
Samsung Biologics NDR Takeaway
Goldman Sachs · May 11, 2026
House View Daily US
UBS · May 11, 2026
Bicara Therapeutics 1Q26 Earnings Update
Goldman Sachs · May 11, 2026
The Options Market Has Flipped
Goldman Sachs & Co. LLC · May 11, 2026
BTG Pactual 1Q26 First Take
Goldman Sachs · May 11, 2026
Hannover Re Data Update Following 1Q26 Results
Goldman Sachs · May 11, 2026
National Bank of Greece Updating Estimates Post Q1
Goldman Sachs · May 11, 2026
Jansen Potash: Keep Investing or Divest?
Goldman Sachs · May 11, 2026
Intellia Therapeutics: Hereditary Angioedema BLA Completion and ATTR Study Updates
Goldman Sachs · May 11, 2026
Modi's Austerity Appeal and Risks of Prolonged Iran War
TS Lombard · May 11, 2026
Fox Corp F3Q26 Earnings First Take
Goldman Sachs · May 11, 2026